Key result
Warfarin therapy resulted in less cognitive decline than placebo over 1 year, with control patients showing significant deterioration in 4 of 25 psychological variables.
Why the study?
The effectiveness of anticoagulant therapy in senile and/or arteriosclerotic dementia was uncertain.
RCT (n=14)
Double-blind
Answers are grounded in this paper and cite their sources.
Small trial precludes practice change; leaves open whether anticoagulation slows cognitive decline in dementia.
A double‐blind, one‐year study was made of the effectiveness of anticoagulant therapy in senile and/or arteriosclerotic dementia. Seven such hospital patients (average age, 83.4 years) were treated with warfarin (sample oral dosage, 2.5 mg daily, monitored according to the prothrombin time). Seven other such patients (average age, 86.4 years) served as controls, and were given placebo tablets. All 14 subjects were assessed with respect to 25 variables reflecting cognitive functions and mental changes, before treatment, and at six and twelve months after starting treatment. The results were evaluated statistically. In the anticoagulant group the t‐tests showed no significant differences for the means in 24 of 25 variables during the one‐year treatment period. The control patients showed no significant changes in the psychological variables after six months; however, after one year, they showed significant deterioration in 4 variables and a trend toward deterioration in most of the others. Thus the anticoagulant group appeared to deteriorate less than the control group. Only further studies will elucidate the possible influence of undertaking therapy in patients who already may have been too deteriorated to benefit from it significantly.
No takes yet. Share an insight, caveat, or question.
Ratner et al. (1972) conducted an RCT in Senile and/or arteriosclerotic dementia (n=14). Warfarin vs. Placebo was evaluated on 25 variables reflecting cognitive functions and mental changes. Warfarin therapy resulted in less cognitive decline than placebo over 1 year, with control patients showing significant deterioration in 4 of 25 psychological variables.
Synapse has enriched 10 related papers. Consider them for comparative context: